- Website
- Locations
- Ireland
- Cork City
- Company size
- 1-10 people
- Total raised
- $327K
- Company type
- B2 B
- Markets
OACP IE careers
OaCP provides patented and CE-IVD chemical reagents that reduce times (-97%) and costs (-50%) of DNA tests for cancer diagnosis. OaCP addresses the Molecular in vitro diagnostics market, starting from the high competitive USD 1b In situ Hybridization one, reaching USD 100K in sales with 100% of CRR and 98% of GM to hospitals and R&D centres. OaCP takes advantage also from a distribution network that covers almost 15 countries globally. Driven by a team with complementary skills in Science, Business, Marketing and Web communication, OaCP undergone to the RebelBio Accelerator program in 2017, receiving, up to today, USD 330k in funding mainly from SOS Venture. OaCP has been awarded in several international competition mainly in Hong Kong and China. Now OaCP is looking for an investment on Euro 1.2M to push, expand and consolidate the market presence, to create a company able to grow organically to bring to the greatest number of cancer patients the best diagnostic technology.
OACP IE hasn't added any jobs yet
Get notified when OACP IE posts new jobs.
Francesco Villa
Giovanni Caputo
Matteo Allegro
Andrea Faviere
Enrico Di Oto
CEO and founder at OaCP S.R.L., founder at DoMo Genetics • PhD degree in Oncology@unibo • Master school in Clinical Pathology @Unibo (University Of Bologna)
Valuation
$2.5M
Funded over
3 rounds
Latest round
Seed (Mar 2020)
Workato • Spain • €96k – €120k • 0.003% – 0.005% • 3 days ago
Inguro • Prague • €3k – €12k • 2.0% – 5.0% • 3 weeks ago
Penumbra • Alameda • $90k – $115k • 4 weeks ago